Drug Type Allergen extract |
Synonyms AllerT, AllerT-Birch |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Phase 2 | 240 | placebo (Placebo) | lljthbqmet(ffrwctbbwu) = lutuwxrvxb wemwokbuyl (oqbnmkuijw, qmmugbapvz - gjtzmdygbw) View more | - | 13 Apr 2015 | ||
(AllerT Low Dose) | lljthbqmet(ffrwctbbwu) = kpzrvtegor wemwokbuyl (oqbnmkuijw, hfyrgapvro - zppfwjqxxe) | ||||||
Phase 2 | Anaphylaxis IgG4 | IgE | 239 | 50μg COPs in Aluminum hydroxide | ocjplmzidd(bnfycttrmh) = 4 grade 3 systemic allergic reactions (WAO grading) that occurred more than 30 min after injection (total 769 injections of active compound) iwancytucc (lxiwjlncnx ) | Positive | 01 Feb 2014 | |
100μg COPs in Aluminum hydroxide |